TJ011133

· I-Mab Biopharma US Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TJ011133, covering 2024-04-15 to 2024-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma [Phase 1]